Replies to post #374635 on NorthWest Biotherapeutics Inc (NWBO)

[Nick119]

It's currently at Phase 2 and they recently updated it to 'Actively Recruiting' whereas previous to that update I believe it was on-hold. There was a post here by someone (I believe ATL) who caught the update. To me the timing of the update of this trial is another bullish signal/breadcrumb: https://clinicaltrials.gov/ct2/show/NCT04201873

Note:
-You'll see ATL-DC here, this is DCVax but the generic version created by UCLA.
-One of the (ludicrous) short arguments here is that ATL-DC has no connection to DCVax, which is untrue. I'd post sources and reasons why, but not going to waste my time.
-Pembrolizumab is the generic name for Keytruda which is owned/operated by MERCK.